Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable selective binding to enzyme active sites, enhancing potency and specificity. The compound's chirality plays a critical role in biological activity, making it valuable in asymmetric synthesis routes. It is also employed in the preparation of fluorinated analogs to improve metabolic stability and bioavailability in drug candidates.